Premature clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
open to all eligible people
A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.